Eye Disease
Cellular Reprogramming Enters Neuro-Ophthalmology
Life Biosciences has dosed the first patient in a Phase 1 trial of ER-100 for optic neuropathies, testing epigenetic restoration in glaucoma and NAION.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.